Article ID Journal Published Year Pages File Type
3902571 Urology 2011 7 Pages PDF
Abstract
The results of the present study have demonstrated that AKAP12 promoter methylation is a frequent event in human PCa. AKAP12 methylation represents a potential molecular biomarker for predicting the malignancy of PCa.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , , , , , ,